Concepedia

Author

Matthew Gornall

University of LiverpoolORCID

Also Known As

Gornall, M, M Gornall, M. Gornall, Matthew Gornall

16

Publications

240

Citations

7

H-Index

13

Concepts

All Affiliations

University of LiverpoolUniversity College LondonQueen Mary University of LondonUniversity of SheffieldUniversity Hospital Coventry
MG

About

Matthew Gornall is an author at University of Liverpool specializing in medicine, pathology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

176

2

Pathology

2

2

176

3

Immunology

1

1

165

4

Surgical Oncology

1

1

11

5

Autoimmune Disease

1

1

165

Matthew Gornall

×

4

Publications

217

Citations

4

H-Index

YearCitations

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients

Daniel Whittam, Álvaro Cobo‐Calvo, A. Sebastian López‐Chiriboga,

Multiple Sclerosis and Related Disorders

2020

165

Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial

J.F. Lester, Richard A. Jackson, Matthew Gornall,

White Rose Research Online (University of Leeds, The University of Sheffield, University of York)

2022

25

Comparing nitisinone 2 mg and 10 mg in the treatment of alkaptonuria—An approach using statistical modelling

L. Ranganath, Anna M. Milan, Andrew T. Hughes,

JIMD Reports

2021

16

Phase II randomized placebo-controlled neoadjuvant trial of nintedanib or placebo with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer (NEO-BLADE).

Syed A. Hussain, J.F. Lester, Richard Jackson,

Journal of Clinical Oncology

2020

11

Page 1